Chronix Biomedical, Inc. is a molecular diagnostics company designing laboratory developed tests for cancer and organ transplants.

CNI Monitor

Provides earliest determination of the efficacy of cancer therapies.


All Chronix tests are blood tests (Liquid biopsy tests) which detect tumor-derived cell-free DNA in blood samples of patients. Gains and losses of large chromosome sections that are present in the genome of cancer cells are detected and combined in a comprehensive copy number instability (CNI) score that can indicate tumor existence, remission or progression. Chronix blood tests are suitable for therapy monitoring for patients with chemotherapy or immunotherapy and for relapse monitoring after tumor resection (CNI MONITOR).


Distributor – UK

Emma Lane

Advanced Cancer Diagnostics, Ltd

+44 207 491 5111

28 Bolton Street, London, W1J 8BP

+44 0 207 629 9933

Distributor – Poland

Elżbieta Ginalska-Markiewicz

Modern Cancer Diagnostics

+48 22 646 46 97

Willowa 2/1 00-790 Warszawa

+48 601 812 775

LBC Logo

LBC is an officially licensed Chronix laboratory offering CNI tests in Europe